Summer Street's chief scientific officer holds analyst/industry conference call Chief Scientific Officer Classen discusses Durect's (DRRX) Posidur for post-operative pain, its safety and whether it could be disruptive to Pacira Pharmaceuticals (PCRX) on an Analyst/Industry conference call to be held on January 8 at 11 am.
News For DRRX;PCRX From The Last 14 Days
Check below for free stories on DRRX;PCRX the last two weeks.
On The Fly: Analyst Initiation Summary Today's noteworthy initiations include: 2U (TWOU) initiated with a Buy at Compass Point... A10 Networks (ATEN) initiated with a Buy at Citigroup... Applied Genetic (AGTC) initiated with a Buy at Cantor... Ashford Hospitality Prime (AHP) initiated with a Hold at Deutsche Bank... Atmos Energy (ATO) initiated with a Neutral at JPMorgan... Navient (NAVIV) initiated with a Buy at Goldman... Pacira Pharmaceuticals (PCRX) initiated with a Buy at BofA/Merrill... Puma Biotechnology (PBYI) initiated with a Buy at Citigroup... Sallie Mae Bank (SLMVV) initiated with a Neutral at Goldman... Square 1 Financial (SQBK) initiated with a Market Perform at Keefe Bruyette.